Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea
Qlaira® Regulatory Post Marketing Surveillance Study in Korea
Sponsor: Bayer
Listed as NCT01797809, this observational or N/A phase trial focuses on Contraception and remains completed. Sponsored by Bayer, it has been updated 13 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
May 2019 — Jan 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Nov 2018 — May 2019 [monthly]
Completed
-
Jun 2018 — Nov 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Feb 2018 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Sep 2017 — Feb 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Apr 2017 — Sep 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bayer
For direct contact, visit the study record on ClinicalTrials.gov .